MedPath

a clinical study to compare stenting with radiotherapy versus stenting with chemoradiotherapy for advanced oesophageal carcinoma patients

Phase 3
Conditions
Health Condition 1: null- patients with inoperable oesophageal carcinoma (ECOG 1-3)
Registration Number
CTRI/2014/04/004534
Lead Sponsor
not applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

i)Oesophageal and gastro oesophageal junction cancer patients with

•Locally advanced unresectable cancer such as invasion of tracheobronchial tree, aorta, pulmonary vascular structures.

•Metastatic disease.

•Comorbid conditions or general health status precluding a major surgical procedure with grade III and IV dysphagia.

•Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) scale

ii)Vocal cord palsy.

iii)Dysphagia grades 3 and 4.

iv)Biopsy proven carcinoma - both squamous cell and adenocarcinoma

Exclusion Criteria

i) Carcinoma of cervical oesophagus

ii) Patients who had already received prior radiation or chemo radiotherapy or any other modality of treatment.

iii) Patients unstable for endoscopic procedure and for radiotherapy/chemoradiotherapy due to severe co-morbid illness such as congestive heart failure, severe hepatic and renal failure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath